LSIPR 50 2017: Robert Nelsen

10-11-2017

Robert Nelsen was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

robert_nelsen.jpg

Name: Robert Nelsen 

Organisation: Arch Venture Partners


LSIPR 50, Robert Nelsen, Arch Venture Partners, investment, Alnylam Pharmaceuticals, Juno Therapeutics, Vir Biotechnology, Sage Therapeutics, Illumina

LSIPR